Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Cancer Genetics Wins 510(k) Clearance for Tissue of Origin Test

Cancer Genetics Wins 510(k) Clearance for Tissue of Origin Test

Apr 16, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Cancer Genetics announced today that it has received special 510(k) clearance from the US Food and Drug Administration for its Tissue of Origin (TOO) gene expression test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Molecular Diagnostics

  1. Roche Continues Expanding Diagnostic Portfolio for SARS-CoV-2 and Beyond

    Premium

  2. Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs

  3. CMS Colon Cancer Screening Memo Bodes Well for Assays in Development; Denies Epi ProColon

  4. FDA Reissues Emergency Use Authorization for Thermo Fisher Scientific COVID-19 Combo Kit

  5. Fluidigm Shares Rise on Selection of Saliva-Based COVID-19 Assay for Federal Surge Testing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.